Reply - 03/08/11

Doi : 10.1016/j.jaci.2011.04.053

Michael Blaiss, MD ^a , Harold S. Nelson, MD ^b, Stephen R. Durham, MD ^c, Ronald Dahl, MD ^d, Albrecht Bufe, MD ^e
^a Departments of Pediatrics and Medicine, University of Tennessee Health Science Center, Memphis, Tenn
^b Department of Medicine, Division of Allergy and Immunology, National Jewish Health, Denver, Colo
^c Section Allergy and Clinical Immunology, National Heart and Lung Institute, Imperial College, London, United Kingdom
^d Department of Respiratory Diseases, Aarhus University Hospital, Aarhus, Denmark
^e Department of Experimental Pneumology, Ruhr-University Bochum, Bochum, Germany

Le texte complet de cet article est disponible en PDF.

Supported by Merck & Co. and ALK-Abelló.

Disclosure of potential conflict of interest: M. Blaiss is a consultant for GlaxoSmithKline, Venture, and Sanofi-Aventis; is a speaker for Merck, AstraZeneca, ISTA, Sepracor, Proctor & Gamble, Alcon, Meda, and Nycomed; has served as an expert witness on the topics of patent antihistamine and wrongful death of a child; and is Treasurer of the Respiratory & Allergic Disease Foundation. H. S. Nelson is a consultant and/or on advisory boards for Genentech, Novartis, Merck, Sepracor, Forest Labs, Pfizer, Planet BioPharma, AstraZeneca, Abbott Labs, DBV Technologies, and Ventura and has received research support from ALK-Abelló. S. R. Durham has provided lectures and consultancy for ALK-Abelló and GlaxoSmithKline; has provided consultancy for Circassia Ltd; and has received research support from ALK-Abelló and Novartis. R. Dahl has received remuneration, such as honoraria or consulting fees, from Boehringer Ingelheim, AstraZeneca, GlaxoSmithKline, ALK-Abelló, Airsonett, Pfizer, MSD, Novartis, and TEVA; has received research support from ALK-Abelló, Stallergenes, Pfizer, Boehringer Ingelheim, AstraZeneca, Novartis, Airsonett, and GlaxoSmithKline; is president of the Danish Respiratory Society; and is Vice Chair of the Global Alliance Against Chronic Respiratory Diseases. A. Bufe is a member of Protectimmun GmbH and has served as a consultant for ALK-Abelló, Denmark; Netstap Forschungs GmbH, Germany; and Bitop AG, Germany.